NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135
(Total Views: 170)
Posted On: 06/15/2022 4:02:13 PM
NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Committed to Building on Its Holistic Approach to Mental Health Wellness
Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, is devoted to finding solutions for mental ailments — not simply by easing symptoms, but by attacking the root causes of the difficulties, utilizing a toolbox of innovative, therapeutic substances. “Recently, Delic announced that six of its clinic locations will launch a specialized therapy that has the potential to boost natural energy stores and immunity, brain and DNA function, and cell communication. The NAD+ (nicotinamide adenine dinucleotide) infusion therapy is administered intravenously or intramuscularly and has previously shown evidence that such treatments support the creation of new cells, neuropathways and networks in the brain, which in turn helps patients recover from various mental health conditions… Those conditions include post-traumatic stress disorder (‘PTSD’), suicidality and chronic pain,” explains a recent article. “At KWC (Delic’s Ketamine Wellness Centers), we are committed to building on our holistic approach to mental health wellness and pursuing the most effective and suitable treatments to address our patients’ needs,” KWC CEO and Delic COO Kevin Nicholson stated.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, is devoted to finding solutions for mental ailments — not simply by easing symptoms, but by attacking the root causes of the difficulties, utilizing a toolbox of innovative, therapeutic substances. “Recently, Delic announced that six of its clinic locations will launch a specialized therapy that has the potential to boost natural energy stores and immunity, brain and DNA function, and cell communication. The NAD+ (nicotinamide adenine dinucleotide) infusion therapy is administered intravenously or intramuscularly and has previously shown evidence that such treatments support the creation of new cells, neuropathways and networks in the brain, which in turn helps patients recover from various mental health conditions… Those conditions include post-traumatic stress disorder (‘PTSD’), suicidality and chronic pain,” explains a recent article. “At KWC (Delic’s Ketamine Wellness Centers), we are committed to building on our holistic approach to mental health wellness and pursuing the most effective and suitable treatments to address our patients’ needs,” KWC CEO and Delic COO Kevin Nicholson stated.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Delic Holdings Corp (DELCF) Stock Research Links
Scroll down for more posts ▼